The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis.

Tanaka, Yoshiya; Atsumi, Tatsuya; Okada, Masato; Miyamura, Tomoya; Ishii, Tomonori; Nishiyama, Susumu; Matsumura, Ryutaro; Kawakami, Atsushi; Hayashi, Nobuya; Abreu, Gabriel; Yavuz, Sule; Lindholm, Catharina; Al-Mossawi, Hussein; Takeuchi, Tsutomu

Tanaka, Yoshiya; Atsumi, Tatsuya; Okada, Masato; Miyamura, Tomoya; Ishii, Tomonori; Nishiyama, Susumu; Matsumura, Ryutaro; Kawakami, Atsushi; Hayashi, Nobuya; Abreu, Gabriel; Yavuz, Sule; Lindholm, Catharina; Al-Mossawi, Hussein; Takeuchi, Tsutomu.

Tanaka Y; First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Atsumi T; Department of Rheumatology, Endocrinology, and Nephrology, Hokkaido University, Sapporo, Japan.
Okada M; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan.
Miyamura T; Department of Internal Medicine and Rheumatology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Ishii T; Department of Hematology and Rheumatology, Tohoku University Hospital, Miyagi, Japan.
Nishiyama S; Rheumatic Disease Center, Kurashiki Medical Center, Kurashiki, Japan.
Matsumura R; Department of Rheumatology, National Hospital Organization, Chiba-East Hospital, Chiba, Japan.
Kawakami A; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hayashi N; Japan R&D, AstraZeneca K.K., Osaka, Japan.
Abreu G; First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Yavuz S; Clinical Development, Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, US.
Lindholm C; Clinical Development, Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Al-Mossawi H; Clinical Development, Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Takeuchi T; Department of Internal Medicine, Keio University School of Medicine, Tokyo, and Saitama Medical University, Saitama, Japan.